Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities
PR News Wire (Free subscription) | 30/11/2009
NEW YORK, Nov. 30 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
From Genetics to Gene Therapy: Molecular Pathology of Human Disease (UCL Molecular Genetics)
Your search relates to more than one category
PR News Wire (Free subscription) | 30/11/2009
NEW YORK, Nov. 30 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Proceedings of the National Academy (Free subscription) | yesterday
Ischemia induces the production of angiogenic cytokines and the homing of bone-marrow-derived angiogenic cells (BMDACs), but these adaptive responses become...
Cool Science News (Free subscription) | 28/11/2009
3D4Medical.com / Getty Images From Time Magazine: At first it sounded like science fiction, curing genetic diseases by giving people new genes. Then it seemed like simple fiction: while theoretically possible, gene therapy appeared unlikely to become a true therapeutic option, the field having suffered years of complications and high-profile setbacks. But over the...
medicalphysicsweb: Industry News (Free subscription) | 27/11/2009
Using ultrasound to target and destroy gene-laden microbubbles shows promise for treating diabetics.
TIME (Free subscription) | 27/11/2009
After years of complications and high-profile setbacks, a series of small but intriguing advances has suggested that gene therapy may hold real future potential for treatment
Medical News Today (Free subscription) | 26/11/2009
Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.
Red Orbit (Free subscription) | 24/11/2009
Image Caption: This image shows the effect of gene therapy combined with cytotoxic agents in E spheroids derived from breast cancer cell line MCF-7. A. Control; B. Doxorubicin 10nm, C. Paclitaxel 10nm, D. Docetaxel 10nm, combined with gene E. Credit: University of Granada
IPWatchdog (Free subscription) | 24/11/2009
Inventors Digest held a youth innovation essay contest, in part to celebrate National Inventors Month, last August. The four winning essays are at InventorsDigest.com. The magazine received and reviewed some 400 essays from across the country. Inventors Digest, in cooperation with IPWatchdog, is showcasing several essays deserving of honorable mention. This is the [...] Related posts:Honorable Mention:...
Red Orbit (Free subscription) | 7 hours ago
AMSTERDAM, December 2 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today a number of management changes.
PR News Wire (Free subscription) | 6 hours ago
AMSTERDAM, December 2 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today a number of management changes. Piers Morgan (age 43) has been appointed Chief Financial Officer, effective December 1, 2009. Hans Preusting, PhD (age 47), Director Process Development & Manufacturing, will take up the responsibility...
PR News Wire (Free subscription) | 6 hours ago
AMSTERDAM, December 2 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today a number of management changes. Piers Morgan (age 43) has been appointed Chief Financial Officer, effective December 1, 2009. Hans Preusting, PhD (age 47), Director Process Development & Manufacturing, will take up the responsibility...
advanced nanotechnology (Free subscription) | yesterday
Chief Medical Correspondent Dr Sanjay Gupta and world-renowned anti-aging experts discussed practical steps for living longer, and cutting-edge research that could dramatically extend human lives. (for about 30 minutes) Geneticist Aubrey de Grey is the Chief Scientific Officer of SENS Foundation, which researches and promotes regenerative medicine. He said that techniques such as stem cell...
1913 Intel (Free subscription) | 28/11/2009
Is Gene Therapy Finally Ready for Prime Time? At first it sounded like science fiction, curing genetic diseases by giving people new genes. Then it seemed like simple fiction: while theoretically possible, gene therapy appeared unlikely to become a true therapeutic option, the field having suffered years of complications and high-profile setbacks. But...
Broader Perspective (Free subscription) | 29/11/2009
... us. Biology evolved to be just good enough to survive and genomics provides the critical next-generation toolkit for its greater exploitation. With the possibility of a complete understanding of biology and the ability to engineer life to be optimum, traditional limits can be overcome, moving from the gene therapies of today (replacing or silencing one gene) to working...
petronel0078u | 27/11/2009
... Hawke plays Sully, a septic-tank cleaner desperate to raise funds for, get this, an in-vitro gene therapy treatment that will boost the IQ of his unborn son. The other main characters are Parmelo (Vincent D'Onofrio), a quirky, mother-loving mob boss who, in one of the film's more ridiculous plot points, winds up in a tree protesting its imminent deforestation, and Jasper (Seymour